Pokkuri Death Syndrome; sudden cardiac death cases without coronary atherosclerosis in South Asian young males

Forensic Science International

Volumn 207, Issue 1-3, 2011, Pages 6-13

  Nakajima, Katsuyuki ^a,c,d   Takeichi, Sanae ^c   Nakajima, Yasuhiro ^a   Fujita, Masaki Q ^a,b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c Takeichi Medical Research Laboratory   (Japan)

^d GUNMA UNIVERSITY   (Japan)

Author keywords

Coronary artery spasm; LOX 1; Pokkuri Death Syndrome (PDS); Remnant lipoproteins (RLP); Rho kinase; Sudden cardiac death (SCD)

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; RHO KINASE;

ATHEROGENESIS; CARDIOVASCULAR RISK; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY SPASM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HYPERLIPOPROTEINEMIA; JAPAN; LIPOPROTEIN BLOOD LEVEL; POKKURI DEATH SYNDROME; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOOTH MUSCLE FIBER; SOUTH ASIA; SUDDEN DEATH; THAILAND; VASODILATATION;

EID: 79953065015     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2010.10.018     Document Type: Review

References (60)

1. Sugai M. A pathological study on sudden and unexpected death, especially on the cardiac death autopsied by medical examiners in Tokyo. Acta Pathol. Jpn. 1959, 9:723-752.
2. Gotoh K A histological study on the conduction system of the so-called " Pokkuri disease" (Sudden unexpected cardiac death of unknown origin in Japan). Jpn. Circ. J. 1976, 40:753-768.
3. Takeichi S., Nakajima Y., Osawa M., Yukawa N., Saito T., Seto Y., Nakano T., Adachi M., Jitsukata K., Horiuchi K., Wang T., Nakajima K. The possible role of remnant-like particles as a risk factor for sudden cardiac death. Int. J. Legal Med. 1997, 110:213-219.
4. Takeichi S., Yukawa N., Nakajima Y., Osawa M., Saito T., Seto Y., Nakano T., Saniabadi A.R., Adachi M., Wang T., Nakajima K K. Association of plasma triglyceride-rich lipoprotein remnants with coronary artery atherosclerosis in cases of sudden cardiac death. Atherosclerosis 1999, 142:309-315.
5. Takeichi S., Nakajima Y., Yukawa N., Saito T., Seto Y., Huang X.-L., Kusakabe T., Jin Z.-B., Hasegawa I., Nakano T., Saniabadi A.R., Adachi M., Ohara N., Wang T., Nakajima K. Association of plasma triglyceride-rich lipoprotein remnants with " Pokkuri disease" Legal Med. 2001, 3:84-94.
6. Takeichi S., Nakajima Y., Yukawa N., Fujita M.Q., Saito T., Satoh F., Seto Y., Kusakabe T., Jin Z.-B., Hasegawa I., Nakano T., Saniabadi A.R., Adachi M., Ohara N., Usui S., Okazaki M., Nakajima K. Validity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary death. Clin. Chim. Acta 2004, 343:93-103.
7. Nakajima K., Nakajima Y., Takeichi S., Fujita M.Q. ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases. Atherosclerosis 2007, 194:473-482.
8. Nakajima K, Nakajima Y., Takeichi S., Fujita M.Q. Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases. Atherosclerosis 2008, 198:237-246.
9. Takeichi S., Fujita M.Q. Unveiling the cause of Pokkuri Disease; proposal of the concept for " Pokkuri Death" Syndrome (in Japanese). J Clin. Exp. Med. (Igaku no Ayumi) 2006, 217(4):347-348.
10. Brugada P., Brugada J. Right bundal branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. J Am. Coll. Cardiol. 1992, 20:1391-1396.
11. Bezzina C., Veldkamp M.W., Van den Berg M.P., Postma A.V., Rook M.B., Viersma J.W., van Langen I.M., Tan-Sindhunata G., Bink-Boelkens M.T., van Der Hout A.H., Mannens M.M., Wilde A.A. A single Na-channel mutation causing both long-QT and Brugada syndromes. Circ. Res. 1999, 85:1206-1213.
12. Nakajima K., Nakano T., Tanaka A. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoprotein in plasma. Clin. Chim. Acta 2006, 367:36-47.
13. Tatsanaviat P., Chiravatkul A., Klungboonkrong V., Chaisiri S., Jarerntanyaruk L., Munger R.G., Saowakontha S. Sudden and unexplained deaths in sleep (Laitai) of young men in rural Northern Thailand. Int. J. Epidemiol. 1992, 21:904-910.
14. Aponite G. The enigma of " Bangungut" Ann. Intern. Med. 1960, 52:1258-1263.
15. Center for Disease Control Sudden, unexpected, nocturnal deaths among Southeast Asian refugees. MMWR 1981, 30:581-589.
16. Takeichi S., Nakajima K., Nakajima Y., Fujita M.Q. Pathological characteristics of Pokkuri Death Syndrome; Narrow circumferences of the coronary arteries in Pokkuri Death Syndrome cases. Atherosclerosis 2008, 200:80-82.
17. Doi H., Kugiyama K., Ohgushi M., Sugiyama S., Matsumura T., Ohta Y., Oka H., Ogata N., Hirata A., Yamamoto Y., Yasue H. Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation. Arterioscl. Thromb. Vasc. Biol. 1999, 19:1918-1922.
18. Fontbonne A., Eschwege E., Cambien F., Richard J.L., Ducimetière P., Thibult N., Warnet J.M., Claude J.R., Rosselin G.E. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989, 32:300-304.
19. Walldius G., Junger W., kolar I., Holme I., Steiner E. High cholesterol and triglyceride values in Swedish male s and females: in creased risk of fatal myocardial infarction. Blood Press Suppl. 1992, 4:35-42.
20. Iso H., Naito Y., Sato S., Kitamura A., Okamura T., Sankai T., Shimamoto T., Iida M., Komachi Y. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am. J. Epidemiol. 2001, 153:490-499.
21. Nordestrgaad B.G., Benn M., Schnohr P., Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007, 298:299-308.
22. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298:309-316.
23. Imke C., Rodriguez B.L., Grove JS J.S., McNamara J.R., Waslien C., Katz A.R., Willcox B., Yano K., Curb J.D. Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu heart study. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1718-1722.
24. Karpe F., Steiner G., Olivecrona T., Carison L.A., Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J. Clin. Invest. 1993, 91:748-758.
25. Ooi T.C., Cousins M., Ooi D.S., Steiner G., Uffelman K.D., Nakajima K., Simo I.E. Postprandial remnant-like lipoproteins in hypertriglyceridemia. J. Clin. Endocrinol. Metab. 2001, 86:3134-3142.
26. Schneeman B.O., Kotite L., Todd K.M., Havel R.J. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoprotein B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:2069-2073.
27. Schneider J., Liesenfeld A., Mordasini R., Schubotz R., Zöfel P., Kubel F., Vandré-Plozzitzka C., Kaffarnik H. Lipoprotein fractions, lipoprotein lipase and hepatic triglyceride lipase during short-term and long-term uptake of ethanol in healthy subjects. Atherosclerosis 1985, 57:281-291.
28. Kugiyama K, Doi H., Motoyama T., Soejima H., Misumi K., Kawano H., Nakagawa O., Yoshimura M., Ogawa H., Matsumura T., Sugiyama S., Nakano T., Nakajima K., Yasue H H. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation 1998, 97:2519-2526.
29. Inoue T., Saniabadi A.R., Matsunaga R., Hoshi K., Yaguchi I., Morooka S. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles. Atherosclerosis 1998, 139:363-367.
30. Kugiyama K., Motoyama T., Doi H., Kawano H., Hirai N., Soejima H., Miyao Y., Takazoe K., Moriyama Y., Mizuno Y., Tsunoda R., Ogawa H., Sakamoto T., Sugiyama S., Yasue H. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoprotein levels. J. Am. Coll. Cardiol. 1999, 33:1512-1518.
31. Funada J., Sekiya M., Hamada M., Hiwada K. Postprandial elevation of remnant lipoproteins lead to endothelial dysfunction. Circ. J. 2002, 66:127-132.
32. Doi H., Kugiyama K., Ohgushi M., Sugiyama S., Matsumura T., Ohta Y., Nakano T., Nakajima K., Yasue H. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. Atherosclerosis 1998, 137:341-349.
33. Doi H., Kukiyama K., Oka H., Sugiyama S., Ogata N., Koide S., Nakamura S., Yasue H. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation 2000, 102:670-676.
34. Ohara N., Takeichi S., Naito Y., Nakajima Y., Yukawa N., Nakano T., Nakajima K. Remnant-like particles from subjects who died of coronary artery disease suppress NO synthase activity and attenuate endothelium-dependent vasorelaxation. Clin. Chim. Acta 2003, 338:151-156.
35. Parthasarathy S., Young S.G., Witztum J.L., Pittman R.C., Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J. Clin. Invest. 1986, 77:641-644.
36. Keary J.F., Xu A., Cunnibgham D., Jackson T., Frei B., Vita J.A. Dietary probucol preserve endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J. Clin. Invest. 1995, 95:2520-2529.
37. Sawamura T., Kume N., Aoyama T., Moriwaki H., Hoshikawa H., Aiba Y., Tanaka T., Miwa S., Katsura Y., Kita T., Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997, 386:73-77.
38. Moriwaki H., Kume N., Sawamura T., Aoyama T., Hoshikawa H., Ochi H., Nishi E., Masaki T., Kita T. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 1998, 18:1541-1547.
39. Kume N., Murase T., Morikawa H H., Aoyama T., Sawamura T., Masaki T., Kita T. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ. Res. 1998, 83:322-327.
40. Kume N., Kita T. Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis. Curr. Opin. Lipidol. 2001, 12:419-423.
41. Shin H.K., Kim Y.K., Kim K.Y., Lee J.H., Hong K.W. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation 2004, 109:1022-1028.
42. Park S.Y., Lee J.H., Kim Y.K., Kim C.D., Rhim B.Y., Lee W.S., HongF K.W. Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation. J. Pharmacol. Exp. Ther. 2005, 312:1241-1248.
43. Kimura Y., Tani T., Kanbe T., Watanbe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneimittelforshung 1985, 35:1144-1149.
44. Wang T., Elam M.B., Forbes W.P., Zhong J., Nakajima K. Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication. Atherosclerosis 2003, 171:337-342.
45. Lee J.H., Oh G.T., Park S.Y., Choi J.H., Park J.G., Kim C.D., Lee W.S., Rhim B.Y., Shin Y.W., Hong K.W. Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol. J. Pharmacol. Exp. Ther. 2005, 313:502-509.
46. Kawakami A., Tanaka A., Chiba T., Nakajima K., Shimokado K., Yoshida M. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Circulation 2003, 108:2679-2688.
47. Aramaki Y., Mitsuoka H., Toyohara M., Jinnai T., Kanatani K., Nakajima K., Mukai E., Yamada Y., Kita T., Inagaki N., Kume N. Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells. Atherosclerosis 2008, 198:272-279.
48. Hussain M.M., Maxfield F.R., Mas-Oliva J., Tabas I I., Ji Z.S., Innerarity T.L., Mahley R.W. Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J. Biol. Chem. 1991, 266:13936-13940.
49. Gianturco S.H., Ramprasad M.P., Song R R., Li R., Brown M.L., Bradley W.A. Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor. Arterioscler. Thromb. Vasc. Biol. 1998, 18:968-976.
50. Takahashi S., Sakai J., Fujino T., Hattori H., Zenimaru Y., Suzuki J., Miyamori I., Yamamoto T. The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J. Atheroscler. Thromb. 2004, 11:200-208.
51. Chen M., Narumiya S., Masaki T., Sawamura T. Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding. Biochem. J. 2001, 355:289-296.
52. Ohi K., Shimokawa H., Hiroki J., Uwatoku T., Abe K., Matsumoto Y., Nakajima Y., Nakajima K., Takeichi S., Takeshita A. Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rho-kinase. Arterioscler. Thromb. Vasc. Biol. 2004, 24:918-922.
53. Shimokawa H H., Ito A., Fukumoto Y Y., Kadokami T., Nakaike R., Sakata M., Takayanagi T., Egashira K., Takeshita A. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J. Clin. Invest. 1996, 97:769-776.
54. Miyata K., Shimokawa H., Kandabashi T., Higo T., Morishige K., Eto Y., Egashira K., Kaibuchi K., Takeshita A. Rho-Kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo. Arterioscler. Thromb. Vasc. Biol. 2000, 20:2351-2358.
55. Tosaka M., Okajima F., Hashiba Y., Saito N., Nagano T., Watanabe T., Kimura T., Sasaki T. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke 2001, 32:2913-2919.
56. Goh K.T., Chao T.C., Chew C.H Sudden nocturnal deaths among Thai construction workers in Singapore. Lancet 1990, 335:1154.
57. Office of the Permanent Secretary, Ministry of Public Health, Report on the implementation of the development project on the quality of life of Thai labours abroad, 1990; Bangkok: Division of Health Education Printer, Ministry of Public Health, 1990.
58. Prechawat S., Sangwatanaroj S., Sunsaneewitayakul B., Stitthisook S., Tosukhowong P., Tungsanga K. Right ventricular electrocardiographic leads for detection of Brugada syndrome in sudden unexplained death syndrome survivors and their relatives. Clin. Cardiol. 2001, 24:776-781.
59. Nademanee K., Veerakul G., Nimmannit S., Chaowakul V., Bhuripanyo K., Likittanasombat K., Tunsanga K., Kuasirikul S., Malasit P., Tansupasawadikul S., Tatsanavivat P. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997, 96:2595-2600.
60. Sangwatanaroj S., Yamanatasneejit P., Sunsaneewitayakul B., Stitthisook S. Linkage analysis and SCN5A mutation screening in five sudden unexplained death syndrome (Lai-Tai) families. J. Med. Assoc. Thai. 2002, 85:S54-S60.